The fentanyls: pharmacological and clinical aspects relevant to Australia.
Saved in:
| Title: | The fentanyls: pharmacological and clinical aspects relevant to Australia. |
|---|---|
| Authors: | Greene, Shaun L (AUTHOR), Scamvougeras, Anton (AUTHOR), Norman, Amanda (AUTHOR), Bonomo, Yvonne (AUTHOR), Castle, David J (AUTHOR) |
| Source: | Australasian Psychiatry. Oct2020, Vol. 28 Issue 5, p542-544. 3p. |
| Subjects: | Medical personnel, Health policy, Pharmaceutical policy |
| Geographic Terms: | Australia |
| Abstract: | |
| Copyright of Australasian Psychiatry is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | <bold>Objective: </bold>North American and other jurisdictions have seen an alarming rise in the abuse of the fentanyls, with related overdose deaths. We sought to review this group of drugs to alert Australian psychiatrists and drug and alcohol clinicians to their clinical effects and potential harms.<bold>Conclusions: </bold>The extreme potency of the fentanyls underlie their lethality. Vigilance and investment from both policy makers and health care providers are required to mitigate harm from a possible future Australian fentanyl epidemic. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 10398562 |
| DOI: | 10.1177/1039856220917317 |
